Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Politics Corrupts Scientific Process at FDA: Videotape Confirms Long-Standing Allegations

WASHINGTON, DC — In a stunning admission, Dr. David Hager confirmed that he was asked to write and submit a memo that sought to derail FDA approval of over-the-counter sales of Plan B emergency contraception (EC).

According to The Washington Post, Hager's memo flew in the face of comprehensive scientific evidence that shows that EC is safe and effective for all women at risk of unintended pregnancy, regardless of age.

In an overwhelming majority vote (23 to 4) in December 2003, two blue-ribbon panels of women's health and drug advisory experts recommended that the FDA grant over-the-counter status for Plan B, the only branded EC product currently on the market.

"Anti-choice fingerprints have been all over emergency contraception since day one," Planned Parenthood Federation of America (PPFA) Interim President Karen Pearl said. "It's hard to say which is more appalling, Dr. Hager's blatant attempt to interfere with the scientific approval process or the FDA's willingness to compromise its credibility and public health mandate. Both are deeply troubling."

EC is the best way to prevent unintended pregnancy in the case of rape, incest, or contraceptive failure. Experts estimate that wider access to EC could prevent 1.7 million unintended pregnancies and 800,000 abortions each year.

The FDA advisory panels' recommendation that EC be made available over-the-counter without prescription was based on overwhelming scientific evidence proving the drug is safe and effective.

Today's Washington Post reports that Dr. Hager delivered a sermon last October at Asbury College chapel in Wilmore, Kentucky, in which he said he was asked to write a "minority opinion" for the commissioner of the FDA.

Hager further claimed his memo was central in convincing the FDA not to abide by the recommendation of its own advisory committees, only the second time in five decades in which the FDA has done so.

Dr. Hager co-authored a book that recommends scriptural passages and prayers for treating premenstrual syndrome, and he is opposed to prescribing contraceptives for unmarried women. His claims that increased access to EC would result in irresponsible behavior is unsubstantiated.

Legitimate studies show that women use EC responsibly, that they do not rely on it as a regular method of contraception, and that greater EC access does not increase sexual activity among teens. The FDA advisory panels concluded that EC meets all FDA requirements for over-the-counter status.

Source

Planned Parenthood Federation of America

Contact

Gustavo Suarez (212) 261-4339
Erin Libit (202) 973-4883

Published

May 13, 2014

We and our third partners use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

We, and our third-party partners, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

User Feedback and Session Replay

On

We use qualitative data from LogRocket, UserZoom, Hotjar and AB Tasty to learn about your user experience and improve our products and services. LogRocket allows us to view session replays.